 | |
Displaying fda PowerPoint Presentations
FDA - Massachusetts Biotechnology Council PPT
Presentation Summary : FDA Inspection Preparation and Management Massachusetts Biotechnology Council April 28, 2009 David L. Chesney, Vice President Strategic Compliance Services
Source : http://www.massbio.org/writable/committees/presentations/fda_inspection_preparation_and_management.ppt
FDA MedWatch and Patient Safety - U S Food and Drug ... PPT
Presentation Summary : FDA MedWatch and Patient Safety FDA MedWatch and Patient Safety Impact of Adverse Events on the Public’s Health 400 B.C. Hippocrates 1999 Institute of Medicine [IOM ...
Source : http://www.accessdata.fda.gov/videos/MedWatch/tutorial/medwatch_patientsafety.ppt
FDA Update on Cord Blood Regulation: New Guidance PPT
Presentation Summary : FDA Update on Cord Blood Regulation: New Guidance Ellen F. Lazarus, M.D., FCAP Director, Division of Human Tissues Office of Cellular, Tissue, and Gene Therapy
Source : http://www.fda.gov/downloads/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/UCM200358.ppt
FDA - Introduction to Drug Regulation - Medical and Public ... PPT
Presentation Summary : FDA - INTRODUCTION TO DRUG REGULATION Edward P. Richards Director, Program in Law, Science, and Public Health Louisiana State University Law Center
Source : http://biotech.law.lsu.edu/cases/FDA/FDA_introduction.ppt
The FDA - Partnerships for Environmental Education and Rural ... PPT
Presentation Summary : Do you know what it stands for? The FDA The FDA is the Food and Drug Administration The FDA is an agency within the U.S. Department of Health and Human Services.
Source : http://peer.tamu.edu/VBB/Lessons/DH/FDA%20Role%20in%20Medicine%20Safety%20and%20Use/FDA%20Role%20in%20Medicine%20Safety%20and%20Use.ppt
Presentation Summary : FDA Study to Characterize Highly Variable Drugs in BE Studies: methods Collected data from 1127 acceptable BE studies, submitted In 524 ANDAs From 2003-2005 ...
Source : http://apps.who.int/prequal/trainingresources/pq_pres/Workshop_KievJune07/english_version/interchang_variabledrugs-EN.ppt
FDA: History and Organization - Medical and Public Health Law ... PPT
Presentation Summary : FDA: History and Organization Edward P. Richards Harvey A. Peltier Professor of Law Louisiana State University School of Law richards@lsu.edu http://biotech.law.lsu.edu
Source : http://biotech.law.lsu.edu/cphl/slides/FDA_history.ppt
FDA CLINICAL TRIAL REQUIREMENTS FOR MEDICAL DEVICES NEIL F. O ... PPT
Presentation Summary : fda clinical trial requirements for medical devices neil f. o’flaherty principal olsson frank weeda terman bode matz pc medical device clinical research and ...
Source : http://www.ofwlaw.com/CM/Custom/FDA%20CLINICAL%20TRIAL%20REQUIREMENTS%20FOR%20MEDICAL%20DEVICES.PPT
FDA Inspections - Home | Partners HealthCare PPT
Presentation Summary : FDA Inspections How to Survive an FDA Inspection Cynthia Monahan, MBA, CIP Quality Improvement Specialist Partners Human Research Quality Improvement Program
Source : http://www.partners.org/phsqi/QIWeb/files/FDA%20Inspections.ppt
FDA Regulation of Product Claims PPT
Presentation Summary : FDA Regulation of Product Claims January 25, 2011 Barbara A. Binzak, Ph.D., J.D., M.A. Attorney Buchanan Ingersoll & Rooney PC Washington, D.C. 202-452-7906
Source : http://www.law.umaryland.edu/programs/health/events/probiotics/documents/Binzak.ppt
HIPAA + Research - Office of Administrative Legal Services PPT
Presentation Summary : FDA Regulation of Drugs, Devices and Biologics By: Lisa A. Wilson University Legal Counsel Office of Administrative Legal Services BMI: 544 Fundamentals of Clinical ...
Source : http://legal.wisc.edu/powerpoint/fda-regs.ppt
ICH-GCP + FDA Regulations Differences - Homepage ... PPT
Presentation Summary : ICH-GCP & FDA Regulations Differences John D. Burke Director, Human Subjects Protection Program University Of Louisville April 21, 2009 ICH-GCP & FDA Regulations ...
Source : http://louisville.edu/research/humansubjects/ICH%20GCP%20-%20FDA%20Regulations%20Differences_4-20-09.ppt
FDA Regulation of Pharmaceuticals and Devices PPT
Presentation Summary : FDA Regulation of Pharmaceuticals and Devices Jean Toth-Allen, Ph.D. Good Clinical Practice Program Office of Science and Health Coordination Office of the Commissioner
Source : http://www.ihs.gov/Research/docs/NativeAmericanconference.ppt
Recalls – An FDA Perspective - NSTA Learning Center PPT
Presentation Summary : LIVE INTERACTIVE LEARNING @ YOUR DESKTOP Food Recall Process Cecilia M. Wolyniak Food and Drug Administration Office of Enforcement Wednesday, December 9, 2009
Source : http://learningcenter.nsta.org/products/symposia_seminars/fall09/fda/files/WS3-12-09-09.ppt
Meetings with FDA - UW Courses Web Server PPT
Presentation Summary : Meetings with FDA Martha A. Feldman, RAC Drug & Device Development Co., Inc. UWE Biomedical Regulatory Affairs Topics for this Session FDA’s views on meetings Kinds ...
Source : http://courses.washington.edu/pharm523/documents/8523%207523%207cp110%20feldman%20Meetings%20with%20FDA%20Nov%2013%202007.ppt
Role of FDA in Guiding Drug Development - NIH Clinical Center ... PPT
Presentation Summary : Principles of Clinical Pharmacology NIH, April 26, 2007 Role of FDA in Guiding Drug Development Carl Peck Center for Drug Development Science UCSF, UC-Washington Center
Source : http://cc.nih.gov/researchers/training/principles/ppt/Peck_2006-2007.ppt
Differences in OHRP, FDA and ICH Regulations/Guidelines PPT
Presentation Summary : Definition of Research . DHHS – “[…] a systematic investigation, including research development, testing and evaluation, designed to develop or contribute to ...
Source : http://hspo.uchc.edu/education_resources/ppt/Differences%20in%20OHRP%20%20FDA%20and%20ICH%20Regulations%20PUBLIC.pptx
Food Labeling - NDSU - North Dakota State University PPT
Presentation Summary : Other FDA Exemptions If you answer “TRUE” to any of the following statements for your business, you may be excused from nutrition labeling.
Source : http://www.ag.ndsu.edu/foodent/entrepreneur/ppt/ins_and_outs_of_food_labeling.ppt
BIMO Program Description - NIH Heart, Lung and Blood Institute PPT
Presentation Summary : FDA investigators that reside organizationally within the Office of Regulatory Affairs or geographically within the FDA District Offices conduct the inspection.
Source : http://www.nhlbi.nih.gov/meetings/FDA-TutorWorkshop/docs/8-Helfgott%20BIMO%20-%20Final.ppt
FDA's Bioresearch Monitoring Inspections - NIH VideoCasting ... PPT
Presentation Summary : FDA Inspections Patricia Holobaugh Chief, Bioresearch Monitoring Branch Division of Inspections and Surveillance Office of Compliance and Biologics Quality
Source : http://videocast.nih.gov/ppt/NIAID_gcp_041505.ppt
Special Issues in FDA-Regulated Studies - VHA Office of ... PPT
Presentation Summary : Special Issues in FDA-Regulated Studies: The Good, the Bad, and the Ugly C. Karen Jeans, MSN, CCRN, CIP COACH Program Analyst VA Office of Research & Development
Source : http://www.research.va.gov/programs/pride/conferences/docs/hrpp201/fda.ppt
An FDA Audit: What the Investigator Needs to Know PPT
Presentation Summary : An FDA Audit: What the Investigator and Sponsor Need to Know Joseph P. Salewski, Chief Bioresearch Monitoring Branch Center for Biologics Evaluation and Research
Source : http://www.asgct.org/archived_course_materials/training_course/salewski.ppt
Presentation Summary : Revising FDA’s “Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests” FDA/Industry Statistics Workshop September 28-29, 2006
Source : https://www.amstat.org/meetings/fdaworkshop/presentations/2006/FDASA%20Guidance%202006-9-29%20Meier.ppt
Preparing for an FDA Audit - Boston Children's Hospital PPT
Presentation Summary : Preparing for an FDA Audit Jean Connor Heidi Moses Eunice Yim Newbert Goals of FDA Audit Ensure quality and integrity of data and information submitted to the FDA ...
Source : http://www.childrenshospital.org/cfapps/research/data_admin/Site2207/Documents/CRA%20Rounds%20-%20Preparing%20for%20FDA%20Audit%20(6-2009).ppt
